Towards a global initiative for fibrosis treatment (GIFT)

Maria Molina-Molina, Alvar Agusti, Bruno Crestani, David A. Schwartz, Melanie Köningshoff, Rachel C. Chambers, Toby M. Maher, Rosa Faner, Ana Lucia Mora, Mauricio Rojas, Katerina M. Antoniou, Jacobo Sellares

Source: ERJ Open Res, 3 (4) 00106-2017; 10.1183/23120541.00106-2017
Journal Issue: October
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Maria Molina-Molina, Alvar Agusti, Bruno Crestani, David A. Schwartz, Melanie Köningshoff, Rachel C. Chambers, Toby M. Maher, Rosa Faner, Ana Lucia Mora, Mauricio Rojas, Katerina M. Antoniou, Jacobo Sellares. Towards a global initiative for fibrosis treatment (GIFT). ERJ Open Res, 3 (4) 00106-2017; 10.1183/23120541.00106-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sustainability of use of an electronic health journal (patientMpower) for pulmonary fibrosis in a US patient support group (PF Warriors) over 180 days.
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018


Burden of idiopathic pulmonary fibrosis (IPF) on quality of life (QoL), work productivity, and healthcare use
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


Treatment of idiopathic pulmonary fibrosis (IPF) with nintedanib: an experience from the compassionate use program (CUP) in Estonia
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017

Reinvestment Fund-Asthma (RF) programme improves the clinical outcomes for asthma patients
Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease
Year: 2010

Asthma control (AC) and quality of life (QoL) 3 months after pulmonary rehabilitation (PR)
Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention
Year: 2010

The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

Adapting local practices can increase compliance and hence outcome of pulmonary rehabilitation (PR) in resource limited settings
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016


Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


The RECHARGE database: Towards a global standard for pulmonary rehabilitation (PR)
Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases
Year: 2019


Patient centred research: a model for involving cystic fibrosis (CF) patients in research planning
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Magnetic-resonance-imaging (MRI) for assessment of regional therapy response in patients with cystic fibrosis (CF)
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


CAT (COPD assessment test) in the initial assessment for pulmonary rehabilitation program
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013

Implementing a pulmonary function laboratory (PFL) quality assurance (QA) program across a large health system
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019


The assessment of burden of COPD (ABC) tool: What counts most?
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Control of asthma at the 3rd-line pulmonary diseases clinics (3rd line pdc) according GINA (global initiative for asthma) parameters
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009


Comparing the chronic respiratory questionnaire-self report (CRQ-SR) and the breathing problems questionnaire (short version) (BPQ-SV) as a quality of life outcome measure for pulmonary rehabilitation (PR)
Source: Annual Congress 2007 - Rehabilitation: measuring, monitoring and maintenance
Year: 2007


Health status (quality of life) of patients with COPD is improved by a specific educational program, Edu-Care
Source: Annual Congress 2004 - Outcome of pulmonary rehabilitation
Year: 2004


Modelling cost effectiveness of a COPD pathway using the Star approach; could cognitive behavioural therapy (CBT) be cost effective in preventing panic-associated admissions?
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016


Feasibility study of an intervention to increase treatment adherence in children with cystic fibrosis (CF)
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019


The German cystic fibrosis quality assurance project: clinical features in children and adults
Source: Eur Respir J 2001; 17: 1187-1194
Year: 2001